700 patients110,866 observations180 daysLIVE

Patient P-02040

Synthetic patientMETA-24 · Day 176 · 35–44 · M · baseline S15Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S15
  2. Day 30 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 43 SC-12 recommendedSupportive Compound SC-12
  4. Day 44 Patient acceptedStarted SC-12 in the companion
  5. Day 50 No meaningful changeSupportive Compound SC-12

What changed?

Trajectory began diverging from predicted response on Day 30.

Primary contributors, last 14 days
  • GI instability+19
  • Nutritional resilience-17
  • Inflammatory activity+14
  • Treatment adherence+3
  • Toxicity-3

What helped?

  • Supportive Compound SC-12Day 43
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
72 min
improving · +2.8 vs previous 14 d
Sleep duration
Wearable
6.6 h
stable · -0.1 vs previous 14 d
Energy level
Daily log
5.4/10
stable · +0.0 vs previous 14 d
Steps
Wearable
6,977
stable · +220 vs previous 14 d
GI burden
Companion
23.9/100
worsening · +1.6 vs previous 14 d
Adherence
Companion
83.7 %
stable · -1.0 vs previous 14 d
Sleep quality
Wearable
42.2/100
worsening · -1.5 vs previous 14 d
Glucose, CGM daily mean
CGM
137 mg/dL
stable · +1.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 58 from the failing basin, 44 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -2.9 next day on high-intake days · n 17
Would not help
  • SC-12 Supportive Compound
    already tried, no meaningful change
  • BR-03 Behavioural Recommendation
    only 22% improved among 9 similar
  • Keep ultra-processed low
    GI +3.7 next day on high-intake days · n 14
  • Keep simple carbs low
    GI +2.9 next day on high-intake days · n 17
  • Keep caffeine low
    GI +1.5 next day on high-intake days · n 14
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Ultra-processed food
    +3.7detractor · 95%
  • Simple carbohydrates
    +2.9detractor · 95%
  • Protein
    -2.9supporter · 87%
  • Caffeine
    +1.5detractor · 61%
  • Dietary fat load
    -1.4no signal · 39%
  • Histamine load
    -1.2no signal · 29%
  • Alcohol
    -0.7no signal · 20%
  • Insoluble fibre
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 60
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 26 ms, trending down
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
  • GLP1R rs6923761 A
    Altered receptor sensitivity
Microbiome
Shannon diversity 2.9 · butyrate capacity 64/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
32 ms
Sleep
6.3 h
Steps
6,841
Resting HR
61 bpm
Daily log: GI score 24, nutritional resilience 56, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0255326%S1371
P-0229327%S15HY-01no change68
P-0209027%S0468
P-0210927%S0466
P-0265827%S0466
P-0209527%S0866
P-0256726%S0366
P-0226627%S0365
P-0221526%S0765
P-0249126%S09DT-01no change65
P-0242326%S1065
P-0258726%S1464